Form 10-K BRAINSTORM CELL THERAPEU For: Dec 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Data at ISCT 2021 New Orleans VIRTUAL Meeting
USA - English
News provided by
Share this article
Share this article
NEW YORK, May 25, 2021 /PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced the presentation today of a poster titled, Molecular Mechanisms Underlying MSC-NTF (NurOwn
®) Exosome Benefits in a Mouse LPS-induced ARDS Model at the ISCT 2021 New Orleans VIRTUAL Meeting, being held from May 25-28, 2021. The poster will be presented during Virtual Poster Hall Session 2: May 25, 20:00-21:30 EDT.
POSTER HIGHLIGHTS:
One of the most severe complications of the current COVID-19 pandemic is acute respiratory distress syndrome (ARDS). ARDS is caused by increased amounts of pro-inflammatory cytokines, leading to severe lung damage and loss of lung function.
BrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Data at ISCT 2021 New Orleans VIRTUAL Meeting prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.